Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 12, 2023 Filed Jan 18, 2023 00:40 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000028 · wf-form4_167400240523604.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:34 UTC |
Souza MarcioDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 425,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000026 · wf-form4_167400207336101.xml · derivative · entry 1 Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,000 Underlying: Common Stock · 425,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:38 UTC |
Sweeny NicoleChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000027 · wf-form4_167400228292631.xml · derivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:30 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000024 · wf-form4_167400181408222.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:32 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000025 · wf-form4_167400190581060.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:14 UTC |
Kelly Timothy EdwinChief Financial Officer
|
Tax withholdingCommon Stock | 2,079 | $2.52 | $5,239.08 |
DisclosureSEC source: 0001689548-23-000005 · wf-form4_167330608086940.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,416 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:19 UTC |
Sweeny NicoleChief Commercial Officer
|
Tax withholdingCommon Stock | 2,079 | $2.52 | $5,239.08 |
DisclosureSEC source: 0001689548-23-000008 · wf-form4_167330636859995.xml · nonDerivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,075 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:18 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
Tax withholdingCommon Stock | 1,335 | $2.52 | $3,364.20 |
DisclosureSEC source: 0001689548-23-000007 · wf-form4_167330631711128.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,694 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:16 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 520 | $2.52 | $1,310.40 |
DisclosureSEC source: 0001689548-23-000006 · wf-form4_167330616920258.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,871 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2022 Filed Nov 21, 2022 11:04 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantCommon Stock | 5 | $1.81 | $9.06 |
DisclosureSEC source: 0001689548-22-000129 · wf-form4_166902868003160.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,495 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 14, 2022 Filed Nov 21, 2022 11:07 UTC |
Souza MarcioDirector · Chief Executive Officer
|
GrantCommon Stock | 2,115 | $1.81 | $3,830.27 |
DisclosureSEC source: 0001689548-22-000131 · wf-form4_166902880883749.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,299 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 14, 2022 Filed Nov 21, 2022 11:03 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantCommon Stock | 682 | $1.81 | $1,235.10 |
DisclosureSEC source: 0001689548-22-000127 · wf-form4_166902858348469.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,029 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:46 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000090 · wf-form4_165610354831826.xml · derivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:45 UTC |
Souza MarcioDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000089 · wf-form4_165610350532146.xml · derivative · entry 1 Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:52 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000094 · wf-form4_165610393075032.xml · derivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:50 UTC |
Sweeny NicoleChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000093 · wf-form4_165610381162995.xml · derivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:47 UTC |
Ravina BernardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000091 · wf-form4_165610361036996.xml · derivative · entry 1 Ravina Bernard · CIK 0001711276 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:48 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000092 · wf-form4_165610371798079.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:35 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
PurchaseCommon Stock | 3,000 | $1.93 | $5,775.00 |
DisclosureSEC source: 0001689548-22-000082 · wf-form4_165584373130613.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,391 Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 23:56 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
PurchaseCommon Stock | 7,500 | $1.63 | $12,225.00 |
DisclosureSEC source: 0001689548-22-000080 · wf-form4_165525096436926.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,347 Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:51 UTC |
Kelly Timothy EdwinChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $1.77 | $17,650.00 |
DisclosureSEC source: 0001689548-22-000078 · wf-form4_165515344848704.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,490 Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 23:25 UTC |
Souza MarcioDirector · Chief Executive Officer
|
PurchaseCommon Stock | 27,000 | $1.85 | $49,887.90 |
DisclosureSEC source: 0001689548-22-000076 · wf-form4_165481709561726.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.835 to $1.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 23:21 UTC |
MITCHELL DEAN JDirector
|
PurchaseCommon Stock | 25,000 | $1.81 | $45,187.50 |
DisclosureSEC source: 0001689548-22-000075 · wf-form4_165481684513057.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.795 to $1.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:27 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000068 · wf-form4_165368682652738.xml · derivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:27 UTC |
Vitorovic StefanDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000067 · wf-form4_165368680552025.xml · derivative · entry 1 Vitorovic Stefan · CIK 0001826967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:26 UTC |
MITCHELL DEAN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000066 · wf-form4_165368676658802.xml · derivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:26 UTC |
Cudkowicz Merit EsterDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000065 · wf-form4_165368673756016.xml · derivative · entry 1 Cudkowicz Merit Ester · CIK 0001856299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:25 UTC |
YOUNG WILLIAM DDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000064 · wf-form4_165368670859170.xml · derivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:25 UTC |
Norden GregoryDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,753 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001689548-22-000063 · wf-form4_165368667461252.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document |
| May 23, 2022 Filed May 25, 2022 01:14 UTC |
DeSimone JillDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,511 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001689548-22-000056 · wf-form4_165344126548499.xml · derivative · entry 1 DeSimone Jill · CIK 0001930479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,511 Underlying: Common Stock · 45,511 shares Expires 2032-05-23 F1 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on May 23, 2022. Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:28 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantCommon Stock | 2,585 | $8.80 | $22,742.83 |
DisclosureSEC source: 0001689548-22-000042 · wf-form4_165290906649531.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,490 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:39 UTC |
Souza MarcioDirector · Chief Executive Officer
|
GrantCommon Stock | 1,392 | $8.80 | $12,246.82 |
DisclosureSEC source: 0001689548-22-000044 · wf-form4_165290990575398.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,184 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:49 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantCommon Stock | 2,202 | $8.80 | $19,373.20 |
DisclosureSEC source: 0001689548-22-000048 · wf-form4_165291056557529.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,847 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:46 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
GrantCommon Stock | 2,557 | $8.80 | $22,496.49 |
DisclosureSEC source: 0001689548-22-000046 · wf-form4_165291013839730.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,391 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:21 UTC |
Sweeny NicoleChief Commercial Officer
|
GrantCommon Stock | 2,587 | $8.80 | $22,760.43 |
DisclosureSEC source: 0001689548-22-000040 · wf-form4_165290886348034.xml · nonDerivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,154 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:40 UTC |
Sweeny NicoleChief Commercial Officer
|
Tax withholdingCommon Stock | 1,233 | $12.85 | $15,844.05 |
DisclosureSEC source: 0001689548-22-000008 · wf-form4_164497200236409.xml · nonDerivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,567 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:38 UTC |
Ravina BernardChief Medical Officer
|
Tax withholdingCommon Stock | 3,057 | $12.85 | $39,282.45 |
DisclosureSEC source: 0001689548-22-000007 · wf-form4_164497188813645.xml · nonDerivative · entry 1 Ravina Bernard · CIK 0001711276 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,476 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:36 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
Tax withholdingCommon Stock | 755 | $12.85 | $9,701.75 |
DisclosureSEC source: 0001689548-22-000006 · wf-form4_164497179947982.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,645 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:35 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 584 | $12.85 | $7,504.40 |
DisclosureSEC source: 0001689548-22-000005 · wf-form4_164497172165661.xml · nonDerivative · entry 1 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,834 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003155 · tm222494-1_4seq1.xml · derivative · entry 2 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC |
Kelly Timothy EdwinChief Financial Officer
|
GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003155 · tm222494-1_4seq1.xml · nonDerivative · entry 1 Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,905 F1 · shares: Mr. Kelly was awarded 24,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:09 UTC |
Souza MarcioDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 259,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003163 · tm222494-5_4seq1.xml · derivative · entry 2 Souza Marcio · CIK 0001707657 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,000 Underlying: Common Stock · 259,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:09 UTC |
Souza MarcioDirector · President and CEO
|
GrantCommon Stock | 74,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003163 · tm222494-5_4seq1.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,792 F1 · shares: Mr. Souza was awarded 74,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:09 UTC |
Sweeny NicoleChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003164 · tm222494-6_4seq1.xml · derivative · entry 2 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:09 UTC |
Sweeny NicoleChief Commercial Officer
|
GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003164 · tm222494-6_4seq1.xml · nonDerivative · entry 1 Sweeny Nicole · CIK 0001827505 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,800 F1 · shares: Ms. Sweeny was awarded 24,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC |
Ravina BernardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 77,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003162 · tm222494-4_4seq1.xml · derivative · entry 2 Ravina Bernard · CIK 0001711276 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 77,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC |
Ravina BernardChief Medical Officer
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003162 · tm222494-4_4seq1.xml · nonDerivative · entry 1 Ravina Bernard · CIK 0001711276 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,533 F1 · shares: Dr. Ravina was awarded 22,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 63,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003160 · tm222494-3_4seq1.xml · derivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 63,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC |
Nemiroff AlexGeneral Counsel and Secretary
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003160 · tm222494-3_4seq1.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 F1 · shares: Mr. Nemiroff was awarded 18,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:07 UTC |
Mastrocola LaurenPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003158 · tm222494-2_4seq1.xml · derivative · entry 2 Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.